/PCLOF
PCLOF Stock - PharmaCielo Ltd.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.02-4.17%
$0.00 (-4.17%) • Dec 19
53
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.91
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.03
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PCLOF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.02 – $0.02
TARGET (TP)$0.03
STOP LOSS$0.02
RISK/REWARD1:2.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.73
52W High$0.07
52W Low$0.02
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $3.48M | $1.54M | $5.31M | $1.94M | $2.65M |
| Gross Profit | $730,878 | $-1,368,837 | $681,288 | $-4,308,365 | $-6,635,811 |
| Gross Margin | 21.0% | -88.8% | 12.8% | -221.5% | -250.0% |
| Operating Income | $-4,902,078 | $-9,700,940 | $-11,434,377 | $-25,193,798 | $-43,396,015 |
| Net Income | $-9,141,476 | $-16,297,635 | $-14,516,351 | $-26,629,693 | $-43,755,809 |
| Net Margin | -262.7% | -1057.1% | -273.5% | -1369.1% | -1648.7% |
| EPS | $-0.05 | $-0.10 | $-0.10 | $-0.18 | $-0.39 |
Company Overview
PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. The company also offers telemedicine software. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia. The company has a strategic alliance with AssuredTrans Inc. PharmaCielo Ltd. is headquartered in Toronto, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PCLOFBeat Rate
17%
Last 12 quarters
Avg Surprise
-174.1%
EPS vs Estimate
Beats / Misses
2/10
Last 12 quarters
Latest EPS
$-0.00
Q4 2025
EPS Surprise History
Q3 23
-176.2%
$-0.02vs$0.02
Q4 23
-157.0%
$-0.01vs$0.02
Q1 24
No data
Q2 24
-134.9%
$-0.01vs$0.03
Q3 24
-136.8%
$-0.01vs$0.03
Q4 24
No data
Q1 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Jan 27, 2026 | — | — | — | — |
Q4 2025 | Dec 5, 2025 | — | $-0.00 | — | — |
Q3 2025 | Aug 28, 2025 | — | — | — | — |
Q1 2025 | Feb 28, 2025 | — | $-0.01 | — | — |
Q4 2024 | Nov 27, 2024 | — | $-0.01 | — | — |
Q3 2024 | Aug 16, 2024 | $0.03 | $-0.01 | -136.8% | ✗ MISS |
Q2 2024 | Jun 26, 2024 | $0.03 | $-0.01 | -134.9% | ✗ MISS |
Q1 2024 | Feb 20, 2024 | — | $-0.03 | — | — |
Q4 2023 | Nov 29, 2023 | $0.02 | $-0.01 | -157.0% | ✗ MISS |
Q3 2023 | Aug 29, 2023 | $0.02 | $-0.02 | -176.2% | ✗ MISS |
Q2 2023 | May 29, 2023 | — | $-0.02 | — | — |
Q2 2023 | Apr 28, 2023 | — | $-0.01 | — | — |
Q4 2022 | Oct 31, 2022 | $-0.01 | $-0.03 | -245.8% | ✗ MISS |
Q3 2022 | Aug 30, 2022 | $-0.02 | $-0.02 | -16.7% | ✗ MISS |
Q2 2022 | May 30, 2022 | $-0.02 | $-0.02 | +2.5% | ✓ BEAT |
Q2 2022 | Apr 29, 2022 | $-0.02 | $-0.02 | +8.6% | ✓ BEAT |
Q4 2021 | Nov 26, 2021 | $-0.03 | $-0.06 | -100.0% | ✗ MISS |
Q3 2021 | Aug 20, 2021 | $-0.03 | $-0.04 | -33.3% | ✗ MISS |
Q2 2021 | May 31, 2021 | $0.05 | $-0.05 | -200.0% | ✗ MISS |
Q2 2021 | May 3, 2021 | $-0.02 | $-0.16 | -900.0% | ✗ MISS |
Latest News
Loading news...
Frequently Asked Questions about PCLOF
What is PCLOF's current stock price?
PharmaCielo Ltd. (PCLOF) is currently trading at $0.02 per share. The stock has moved -4.17% today.
What is the analyst price target for PCLOF?
No analyst price targets are currently available for this stock.
What sector is PharmaCielo Ltd. in?
PharmaCielo Ltd. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is PCLOF's market cap?
PharmaCielo Ltd. has a market capitalization of $0.00 billion, making it a small-cap company.
Does PCLOF pay dividends?
No, PharmaCielo Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAUSAF
Australis Capital Inc.
$0.00
Mkt Cap: $0.0B
AVTBF
Avant Brands Inc.
$0.74
Mkt Cap: $0.0B
BBRRF
Blueberries Medical Corp.
$0.01
Mkt Cap: $0.0B
BUDZ
WEED, Inc.
$0.07
Mkt Cap: $0.0B
CANN
Trees Corporation
$0.04
Mkt Cap: $0.0B
CPIVF
Captiva Verde Wellness Corp.
$0.02
Mkt Cap: $0.0B
IONKF
Ionic Brands Corp.
$0.00
Mkt Cap: $0.0B
LOBEF
Lobe Sciences Ltd.
$0.00
Mkt Cap: $0.0B
THCBF
THC Biomed Intl Ltd.
$0.00
Mkt Cap: $0.0B
VDQSF
Gnomestar Craft Inc.
$0.01
Mkt Cap: $0.0B
Explore stocks similar to PCLOF for comparison